Delivery Order SPE2DX22D0010-SPE2D823FLB34
Award Date
5/24/23
Potential Completion Date
5/25/23
Potential Value
$20K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,602.80, is for the delivery of 4,567,060,475 units of Vyvanse 50 mg capsules. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,969.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,561,418,336 units of Vyvanse 20 mg capsules. The contract has an ultimate completion date of July 6, 2023 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,219.03, is for the delivery of 4,562,853,174 units of Vyvanse 30 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a firm fixed price, ceiling value of $1,121.72, and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including Vyvanse 30 mg capsules, for a not-to-exceed value of $3,291.65. The contract is a Firm Fixed Price Delivery Order with a period of performance through September 27, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Vyvanse 20 mg capsules. The $17,302.68 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,560,970,387 units of Vyvanse 30 mg capsule. The contract has a firm fixed price of $1,634.63 and an ultimate completion date of May 18, 2023. This is a delivery order contract and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $25,240.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 70mg Vyvanse capsules and has a completion date of July 3, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,333.26, is for the delivery of Vyvanse capsules, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,680.05 firm fixed-price delivery order contract is for the supply of Vyvanse 20 mg capsules. The contract has a completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...